Regis Corporation Q1 2026 Earnings Positive EPS Achieved Amid Limited Revenue Disclosure Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady FBLG Q1 2026 Earnings PreRevenue Biotech Posts Slight EPS Miss No Revenue Reported KALV Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues BSRR Q1 2026 Earnings Earnings Surpass Estimates on Improved Operating Performance APO Q1 2026 Earnings EPS Slightly Misses Estimate Stock Holds Steady